Wells Fargo Cuts Price Target Range on Endo Pharmaceuticals (ENDP); Continued Uncertainty About Timing of Generic Lidoderm
Tweet Send to a Friend
Wells Fargo maintains a 'Market Perform' on Endo Pharmaceuticals (NASDAQ: ENDP) price target range $31-$34 (from $36-$39)
Analyst, Michael ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Analyst, Michael ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
